"Designing Growth Strategies is in our DNA"

Specialty Generics Market Size, Share & Industry Analysis, By Route of Administration (Injectable, Oral, and Others), By Indication (Oncology, Cardiovascular, Autoimmune Diseases, Infectious Diseases, and Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and Regional Forecast, 2024-2032

Last Updated: February 03, 2025 | Format: PDF | Report ID: FBI107533

 


To get information on various segments, share your queries with us

ATTRIBUTE

DETAILS

Study Period

2019-2032

Base Year

2023

Estimated Year

2024

Forecast Period

2024-2032

Historical Period

2019-2022

Growth Rate

CAGR of 15.5% from 2024-2032

Unit

Value (USD Billion)

Segmentation

By Route of Administration

  • Injectable
  • Oral
  • Others

By Indication

  • Oncology
  • Cardiovascular
  • Autoimmune Diseases
  • Infectious Diseases
  • Others

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

By Region

  • North America (By Route of Administration, By Indication, By Distribution Channel, and By Country)
    • U.S.
    • Canada
  • Europe (By Route of Administration, By Indication, By Distribution Channel, and By Country/Sub-Region)
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Route of Administration, By Indication, By Distribution Channel, and By Country/Sub-Region)
    • India
    • China
    • Japan
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
    • Rest of the World ( By Route of Administration, By Indication, and By Distribution Channel)
  • 2019-2032
  • 2023
  • 2019-2022
  • 151
Multi-report Purchase Plan
    A Customized Plan Will be Created Based on the number of reports you wish to purchase